ARCHIVES

Final Issue of ‘78

This article is from The Cancer Letter archive.

Vol. 04 No. 50 | December 15, 1978

Download PDF Visit The Full Archive

Related Articles

NCI To require Prompt Publication Of Data Affected By Falsification In Future Grants

April 8, 1994

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

NCI Advisory Group, Other Cancer Meetings

May 29, 1987

Antoine To Leave As RP Director, Will Join ROB

November 2, 1990

51% Control Rate Achieved In Phase II Trial of Elderly Patients

March 29, 2013